Screener
Prime Medicine PRME Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | June 30,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 17,077 | 20,572 |
| Operating lease right-of-use assets | 120,468 | 126,177 |
| Restricted cash | 13,691 | 13,691 |
| Other assets | 1,000 | 1,000 |
| Total assets | $249,040 | $342,733 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $5,808 | $8,887 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's deferred tax assets and other non-current assets?
- Prime Medicine (PRME) reported deferred tax assets and other non-current assets of $1M in Q2 2026.
- What is the long-term trend for Prime Medicine's deferred tax assets and other non-current assets?
- Over 4 years (2021 to 2025), Prime Medicine's deferred tax assets and other non-current assets has grown at a -20.3% compound annual growth rate (CAGR), from $2.47M to $1M.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Prime Medicine's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude